Last reviewed: June 16, 2026
Last updated: June 16, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
When you lose weight, your body can break down both fat and muscle tissue—a process called catabolism. Semaglutide helps you lose weight by reducing hunger and slowing stomach emptying, but questions persist about whether it specifically targets muscle. The evidence reveals a more nuanced story than headlines suggest.
How GLP-1 Medications Affect Body Composition
Semaglutide works by activating GLP-1 receptors in your brain and stomach, which decreases appetite and increases feelings of fullness. This mechanism leads to reduced calorie intake without directly attacking muscle tissue. When weight loss happens, your body naturally uses both fat and lean mass for energy unless you actively preserve muscle through exercise and adequate protein.
Clinical trials show that patients on semaglutide lose approximately 15-22% of their starting body weight over 68 weeks. Importantly, studies measuring body composition reveal that the majority of this loss comes from fat tissue, not muscle. The ratio of fat loss to lean mass loss depends heavily on your exercise routine, protein consumption, and overall lifestyle during treatment.
The Muscle Preservation Factor: Exercise and Protein Matter Most
Research demonstrates that muscle loss during weight reduction is primarily driven by inactivity and insufficient protein intake, not by semaglutide itself. When patients maintain regular resistance training and consume 0.7-1.0 grams of protein per pound of body weight, lean mass preservation improves significantly. Your individual genetic predispositions, measured through the PlexusDx Precision Peptide Genetic Test, can reveal how your body metabolizes peptides like GLP-1—information that helps personalize your approach to nutrition and exercise.
A 2023 analysis of GLP-1 therapy found that participants who combined medication with structured exercise programs retained 80-90% of their lean muscle mass while losing substantial fat. Those who remained sedentary experienced greater relative muscle loss. This finding underscores that semaglutide is a tool that works best alongside active lifestyle choices, not a replacement for them.
Comparing Semaglutide to Other Weight Loss Methods
Traditional calorie restriction without medication often produces a 25-30% lean mass loss relative to total weight loss. Semaglutide-assisted weight loss typically shows a 15-20% lean mass loss ratio, meaning the medication actually improves body composition outcomes compared to diet alone. This occurs because reduced appetite leads to more moderate calorie deficits rather than extreme restriction, which is gentler on muscle tissue.
Dual-compound approaches like PlexusDx GLP-Squared (combining semaglutide and tirzepatide) may offer additional metabolic advantages by targeting multiple peptide pathways. Tirzepatide, a GIP/GLP-1 receptor agonist, has shown favorable lean mass retention in early studies. Compounded options from licensed 503A pharmacies allow tailored dosing strategies that can be adjusted based on your individual response and composition goals.
Practical Steps to Protect Muscle While Using Semaglutide
Strength training 3-4 times weekly is your primary defense against unwanted muscle loss during semaglutide therapy. Focus on compound movements like squats, deadlifts, and presses that engage large muscle groups. Combined with consistent resistance work, consuming adequate protein at each meal helps your body retain lean tissue even in a calorie deficit.
PlexusDx patients can access personalized guidance by pairing their semaglutide injection (starting at $149/mo) with the Precision Peptide Genetic Test ($99 add-on). This genetic assessment identifies your peptide pathway sensitivity and metabolic tendencies, enabling your provider to recommend protein targets and exercise protocols tailored to your biology. Regular monitoring and dose adjustments ensure you're losing weight efficiently while preserving the muscle mass that supports your metabolism long-term.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does semaglutide specifically eat muscle tissue?
No. Semaglutide reduces appetite and calorie intake, but it does not directly attack muscle. When weight loss occurs, your body naturally breaks down both fat and lean mass. The ratio of muscle lost depends on your exercise routine and protein intake, not the medication itself.
What does clinical research say about muscle loss on GLP-1 drugs?
Studies show that semaglutide-assisted weight loss results in 15-20% lean mass loss relative to total weight lost, compared to 25-30% with diet-only approaches. Patients who combine medication with resistance training retain 80-90% of their lean muscle mass while losing significant fat.
How much protein should I eat while on semaglutide?
Aim for 0.7-1.0 grams of protein per pound of your target body weight daily. This supports muscle retention during weight loss. PlexusDx providers can offer personalized nutrition guidance, especially when paired with the Precision Peptide Genetic Test, which reveals your individual metabolic tendencies.
Can I use semaglutide safely if I want to preserve muscle?
Yes. Semaglutide is safe and effective when combined with resistance training and adequate protein. In fact, medication-assisted weight loss often produces better body composition outcomes than restrictive dieting alone because the calorie deficit is more moderate and sustainable.
How does the PlexusDx Precision Peptide Genetic Test help with muscle preservation?
The test analyzes 14 peptide pathways and identifies genetic variants affecting how your body responds to GLP-1 therapy. Understanding your individual peptide sensitivity helps your provider recommend optimal protein intake, exercise intensity, and even compound selection—ensuring your semaglutide plan maximizes fat loss while protecting lean tissue.
What is the minimum exercise needed to keep muscle on semaglutide?
Resistance training 3-4 times weekly, focusing on compound movements, provides robust muscle protection. Even moderate-intensity strength work paired with adequate protein significantly reduces lean mass loss compared to sedentary weight loss approaches.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Will I Keep Losing Weight on Ozempic? Understanding the Journey of Weight Loss with Semaglutide
Can You Take Cold Medicine with Ozempic? Navigating Your Health on a Weight Loss Journey